Clinical trial
Ketamine for the Treatment of Rett Syndrome: An Exploratory Trial
NCT02562820 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ketamine for the Treatment of Rett Syndrome: An Exploratory Trial
- Lead sponsor
- The Cleveland Clinic
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- November 30, 2015
- Completion date
- July 31, 2017
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.